Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1284-2023Class II

G7 Acetabular System, Dual Mobility Acetabular Liner, 40 mm, Size D, Model Number 110024462

Zimmer GmbH / initiated 2023-02-06 / Open, Classified / root cause: labeling and UDI

Biomet, Inc. began a recall of G7 Acetabular System, Dual Mobility Acetabular Liner, 40 mm, Size D, Model Number 110024462 on . FDA classified it as Class II and gives the reason as "The outer package labeling and product etch are a 40 mm Size D liner, however, the implant is a 38 mm Size C liner". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1284-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Zimmer GmbH
Product
G7 Acetabular System, Dual Mobility Acetabular Liner, 40 mm, Size D, Model Number 110024462
Product code
LPH Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented
Reason for recall
The outer package labeling and product etch are a 40 mm Size D liner, however, the implant is a 38 mm Size C liner.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
An "URGENT MEDICAL DEVICE RECALL" notification letter dated 2/6/23 was sent to customers. The customers were instructed to do the following: 1. Review this notification and ensure that affected team members are aware of the contents. 2. Immediately locate and quarantine affected product in your inventory. 3. Immediately return all affected product from your distributorship and from affected hospitals within your territory. a. Complete Inventory Return Certification Form for each return and send to [email protected]. This form must be returned even if you do not have affected products available to return in your territory. b. Include a hardcopy of the completed form in each carton of your return shipment for immediate processing. c. Mark RECALL on the outside of the returned cartons. 4. Return the Additional Accounts form to [email protected]. a. Review the list of hospitals included with the email notification sent to your facility, which includes a list of hospitals that have already been notified of this recall. b. Identify whether there are any additional hospitals that Zimmer Biomet has not notified and list these accounts on the Additional Accounts form. Please provide the form in Excel format. c. If there are no additional accounts to notify, please indicate that there are no additional accounts, or indicate None or NA on the form. 5. Retain a copy of your Inventory Return Certification and product return forms for your records in the event of a compliance audit of your facility. 6. If you have further questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday or email: [email protected]. Calls received outside of call center operating hours will receive a voicemail prompt or be transferred to an on-call representative in the event of an emergency.
Quantity in commerce
12 units
Distribution
US Distribution to states of: AZ, FL, GA, MI, NE, and TX.
Product codes and lots
UDI: (01)00880304703506(17)321128(10)65731960; Lot Number: 65731960

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1284-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1284-2023Class IIOngoingVoluntary: Firm initiated